Payment overview · 2025
General Payments
$55,492.74
145 reported records · 17 companies
Healthcare provider profile · identity verified
Carleen Cho, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · ERIE, PA · NPI 1205231982
Verified facts
What the public records show
CMS Open Payments records show Carleen Cho, MD received $55,492.74 in general payments during 2025 across 145 reported records.
Smith+Nephew, Inc. accounted for 85.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 45 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $47,528.66 | 85.7% | 58 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $1,800.22 | 3.2% | 12 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $1,601.88 | 2.9% | 18 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $1,500.00 | 2.7% | 1 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $1,178.73 | 2.1% | 23 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $542.97 | 1.0% | 1 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $530.28 | 1.0% | 13 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $403.69 | 0.7% | 6 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $184.94 | 0.3% | 4 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $78.44 | 0.1% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $34.43 | 0.1% | 2 | 2025 |
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $23.62 | 0.0% | 1 | 2025 |
| Regeneron Healthcare Solutions, Inc. | Unresolved — no canonical attribution shown | $21.39 | 0.0% | 1 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $19.17 | 0.0% | 1 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $15.49 | 0.0% | 1 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $15.36 | 0.0% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $13.47 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,743.75 | 5 |
| Travel and Lodging | $10,708.27 | 34 |
| Food and Beverage | $5,540.72 | 105 |
| Long term medical supply or device loan | $1,500.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| GRAFIX Normalized: grafix |
Biological | Smith+Nephew, Inc. | $37,832.64 | 24 | 2025 |
Source payment records
|
|||||
| GRAFIX PL Normalized: grafix pl |
Biological | Smith+Nephew, Inc. | $27,048.92 | 12 | 2025 |
Source payment records
|
|||||
| GRAFIX XC Normalized: grafix xc |
Biological | Smith+Nephew, Inc. | $27,012.97 | 9 | 2025 |
Source payment records
|
|||||
| STRAVIX Normalized: stravix |
Biological | Smith+Nephew, Inc. | $19,069.60 | 13 | 2025 |
Source payment records
|
|||||
| NA Normalized: na |
Device | Smith+Nephew, Inc. | $18,986.79 | 5 | 2025 |
Source payment records
|
|||||
| OASIS Normalized: oasis |
Device | Smith+Nephew, Inc. | $16,788.35 | 12 | 2025 |
Source payment records
|
|||||
| Versajet Normalized: versajet |
Device | Smith+Nephew, Inc. | $9,347.50 | 18 | 2025 |
Source payment records
|
|||||
| OASIS MICRO Normalized: oasis micro |
Device | Smith+Nephew, Inc. | $8,071.38 | 5 | 2025 |
Source payment records
|
|||||
| PICO Normalized: pico |
Device | Smith+Nephew, Inc. | $2,237.20 | 9 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $1,862.95 | 11 | 2025 |
Source payment records
|
|||||
| Auryon Laser System 100-120 Vac Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $1,500.00 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis Normalized: gore viabahn endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $1,405.00 | 9 | 2025 |
Source payment records
|
|||||
| STRAVIX PL Normalized: stravix pl |
Biological | Smith+Nephew, Inc. | $989.24 | 3 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $780.44 | 5 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $780.44 | 5 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $414.77 | 5 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $395.52 | 11 | 2025 |
Source payment records
|
|||||
| STRAVIX MESH Normalized: stravix mesh |
Biological | Smith+Nephew, Inc. | $380.87 | 6 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $309.96 | 4 | 2025 |
Source payment records
|
|||||
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $275.00 | 4 | 2025 |
Source payment records
|
|||||
| VENACORE THROMBECTOMY CATHETER Normalized: venacore thrombectomy catheter |
Device | Stryker Corporation | $268.19 | 4 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $263.63 | 4 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $258.84 | 5 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $168.39 | 3 | 2025 |
Source payment records
|
|||||
| "ACTICOAT 4"" X 4""" Normalized: acticoat 4 x 4 |
Device | Smith+Nephew, Inc. | $166.00 | 1 | 2025 |
Source payment records
|
|||||
| GORE ACUSEAL Vascular Graft Normalized: gore acuseal vascular graft |
Device | W. L. Gore & Associates, Inc. | $146.05 | 7 | 2025 |
Source payment records
|
|||||
| RENASYS TOUCH Normalized: renasys touch |
Device | Smith+Nephew, Inc. | $126.43 | 8 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $101.70 | 1 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL VENOUS Normalized: mynx control venous |
Device | CORDIS US CORP. | $78.44 | 1 | 2025 |
Source payment records
|
|||||
| AMPLATZ Normalized: amplatz |
Device | Cook Medical LLC | $74.59 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $50.83 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $34.43 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $34.43 | 2 | 2025 |
Source payment records
|
|||||
| VIVITROL Normalized: vivitrol |
Drug | Alkermes, Inc. | $23.62 | 1 | 2025 |
Source payment records
|
|||||
| INTHRILL THROMBECTOMY CATHETER Normalized: inthrill thrombectomy catheter |
Device | Stryker Corporation | $22.86 | 3 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $21.42 | 1 | 2025 |
Source payment records
|
|||||
| EVKEEZA Normalized: evkeeza |
Biological | Regeneron Healthcare Solutions, Inc. | $21.39 | 1 | 2025 |
Source payment records
|
|||||
| LEMAITRE EMBOLECTOMY CATHETER Normalized: lemaitre embolectomy catheter |
Device | LeMaitre Vascular, Inc. | $19.17 | 1 | 2025 |
Source payment records
|
|||||
| ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM Normalized: icast covered stent system 6mmx22mmx120cm |
Device | Cook Medical LLC | $19.14 | 1 | 2025 |
Source payment records
|
|||||
| ALLEVYN HEEL 10.5CM X 13.5CM CTN 5 Normalized: allevyn heel 10 5cm x 13 5cm ctn 5 |
Device | Smith+Nephew, Inc. | $18.76 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $16.55 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $16.55 | 1 | 2025 |
Source payment records
|
|||||
| IGT Devices Systems Undivided Normalized: igt devices systems undivided |
Device | Philips North America LLC | $15.49 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $13.47 | 1 | 2025 |
Source payment records
|
|||||
| REVCORE THROMBECTOMY CATHETER Normalized: revcore thrombectomy catheter |
Device | Stryker Corporation | $4.62 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 33 | 12 |
| Xarelto | Rivaroxaban | 16 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $55,492.74 · 145 records | Smith+Nephew, Inc. | "ACTICOAT 4"" X 4""", AFX2 Bifurcated Endograft System, ALLEVYN HEEL 10.5CM X 13.5CM CTN 5, AMPLATZ, ARTIX MT, Alto Abdominal Stent Graft System, Auryon Laser System 100-120 Vac, CLOTTRIEVER BOLD CATHETER, COLLAGENASE SANTYL, CT THROMBECTOMY SYSTEM KIT, EVENITY, EVKEEZA, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, GORE ACUSEAL Vascular Graft, GORE VIABAHN Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin, GRAFIX, GRAFIX PL, GRAFIX XC, ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM, IGT Devices Systems Undivided, INTHRILL THROMBECTOMY CATHETER, Kerecis GraftGuide, Kerecis SurgiClose, LEMAITRE EMBOLECTOMY CATHETER, LIMFLOW SYSTEM, MYNX CONTROL VENOUS, NA, OASIS, OASIS MICRO, PICO, PROLIA, RENASYS TOUCH, REPATHA, REVCORE THROMBECTOMY CATHETER, STRAVIX, STRAVIX MESH, STRAVIX PL, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, VENACORE THROMBECTOMY CATHETER, VIVITROL, VRAYLAR, Versajet, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error